Moderna, Inc.
Moderna’s mRNA technology quickly enabled Moderna to pivot when the COVID-19 crisis emerged and to manufacture and deliver a safe, effective vaccine against COVID-19.
Lobbying Activity
Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur) and Vaccines Europe
10 Sept 2025 · Critical Medicines Act
Meeting with Florika Fink-Hooijer (Director-General Health Emergency Preparedness and Response Authority)
2 Jun 2025 · Pandemic preparedness
Meeting with Stelios Kympouropoulos (Member of the European Parliament) and BioNTech SE
17 Jan 2024 · Kangaroo Lunch debate on Platform Technologies and the pharmaceutical legislation review
Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur) and BioNTech SE
16 Jan 2024 · Pharmaceutical legislation
Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion) and BioNTech SE
30 Oct 2023 · Pharmaceutical Package (Directive)
Meeting with Tiemo Wölken (Member of the European Parliament) and
18 Oct 2023 · Pharma Revision - Directive (staff level)
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and
13 Oct 2023 · Directive on Medicinal products for human use
Meeting with István Ujhelyi (Member of the European Parliament)
3 May 2023 · Health
Meeting with Nathalie Colin-Oesterlé (Member of the European Parliament) and Novartis International AG
3 May 2023 · Pharmaceutical review
Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)
10 Nov 2022 · Lessons learned on impact of COVID-19 pandemic
Meeting with Stella Kyriakides (Commissioner) and
3 Nov 2022 · Videoconference with Moderna CEO on future of mRNA platform; ongoing cooperation on the management of the pandemic
Meeting with Stelios Kympouropoulos (Member of the European Parliament)
11 Oct 2022 · Lessons-learnt from COVID-19
Meeting with Karsten Lucke (Member of the European Parliament)
22 Jul 2022 · Corona Impfstoffe
Meeting with Kathleen Van Brempt (Member of the European Parliament, Committee chair)
31 May 2022 · The current situation of the pandemic and the mRNA technology
Meeting with Ursula von der Leyen (President)
26 Nov 2021 · Meeting with CEO of Moderna
Meeting with Thierry Breton (Commissioner)
10 Apr 2021 · Vaccine production and deliveries
Meeting with Ursula von der Leyen (President) and
31 Jan 2021 · Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements